Kiniksa Pharmaceuticals International

1D
1W
1M
3M
YTD
1Y
5Y
ALL

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell KNSA and other ETFs, options, and stocks.

About KNSA

Kiniksa Pharmaceuticals International Plc is a commercial-stage biopharmaceutical company. It engages in discovering, acquiring, developing, and commercializing therapeutic medicines for patients suffering from debilitating diseases with significant unmet medical need. 

CEO
Sanj K. Patel
CEOSanj K. Patel
Employees
315
Employees315
Headquarters
London, Greater London
HeadquartersLondon, Greater London
Founded
2024
Founded2024
Employees
315
Employees315

KNSA Key Statistics

Market cap
2.87B
Market cap2.87B
Price-Earnings ratio
946.96
Price-Earnings ratio946.96
Dividend yield
—
Dividend yield—
Average volume
381.97K
Average volume381.97K
High today
$39.14
High today$39.14
Low today
$37.85
Low today$37.85
Open price
$38.90
Open price$38.90
Volume
188.97K
Volume188.97K
52 Week high
$39.43
52 Week high$39.43
52 Week low
$17.82
52 Week low$17.82

Analyst ratings

100%

of 7 ratings
Buy
100%
Hold
0%
Sell
0%

People also own

Based on the portfolios of people who own KNSA. This list is generated using Robinhood data, and it’s not a recommendation.
Shopify
Trade Desk
Micron Technology
Taiwan Semiconductor Manu…
Rocket Lab Corporation
CrowdStrike Holdings
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, Member SIPC and a registered broker-dealer.